首页 | 本学科首页   官方微博 | 高级检索  
   检索      

减毒沙门氏菌介导的血小板第四因子活性片段的放射保护作用研究
引用本文:刘斌,赵丽华,李彬,余晓菲,冯义,卢士红,韩忠朝.减毒沙门氏菌介导的血小板第四因子活性片段的放射保护作用研究[J].中国生物工程杂志,2005,25(3):23-25,27-28.
作者姓名:刘斌  赵丽华  李彬  余晓菲  冯义  卢士红  韩忠朝
作者单位:中国医学科学院中国协和医科大学血液学研究所实验血液学国家重点实验室国家干细胞工程技术研究中心 天津 300020
基金项目:国家杰出青年科学基金 (3 972 5 0 14 ),国家自然科学基金(3 9780 0 0 7),国家“ 863”计划资助项目 (2 0 0 1AA2 15 3 11,2 0 0 2AA2 2 3 3 5 4),国家“973”计划资助项目 (0 0 1CB5 10 1)
摘    要:目的:观察减毒沙门氏菌携带的血小板第四因子活性片段PF417 70 的放射保护作用。方法:通过口服途经喂饲小鼠携带PF4活性片段的减毒沙门氏菌,在第 2次喂饲后小鼠接受 70 0cGy全身照射,然后观察PIRES2 EGFP PF417 70 在小鼠体内的表达,并观察小鼠的造血恢复情况。结果:在小鼠的肝脏、脾脏、肾脏、小肠、外周血及骨髓均能检测到GFP的表达和转基因的整合。与对照组比较,实验组小鼠的生存期明显延长,照射后第 7d和 1 4d骨髓有核细胞数、骨髓培养的CFU GM和HPP CFC数量明显增加 (P <0 0 5 )。结论:首次应用减毒沙门氏菌SL32 61为载体来介导PF4活性片段的生物学作用,并证实通过口服途径可以保护小鼠免受放射损伤,并促进放射损伤后小鼠的造血恢复。

关 键 词:减毒沙门氏菌  放疗保护  口服  PF41770  

Radiation Protection of Platelet Factor 4 Fragment(PF417-70) Using Attenuated Salmonella as Oral Vectors for Gene Delivery
LIU Bin,ZHAO Li-hua,LI Bin,YU Xiao-fei,FENG Yi,LU Shi-hong,HAN Zhong-chao.Radiation Protection of Platelet Factor 4 Fragment(PF417-70) Using Attenuated Salmonella as Oral Vectors for Gene Delivery[J].China Biotechnology,2005,25(3):23-25,27-28.
Authors:LIU Bin  ZHAO Li-hua  LI Bin  YU Xiao-fei  FENG Yi  LU Shi-hong  HAN Zhong-chao
Abstract:Objective: To study the radiation protection effect of PF4 17-70 on mice from total body irradiation using attenuated salmonella as gene delivery vectors. Methods: A live attenuated aroA-autotrophic mutant of salmonella typhimurium (SL3261) was used as carrier for eukaryotic vector PIRES2-EGFP/PF4 17-70 and was administered orally to BALB/C once at 3 day intervals. After the second oral administration the mice were injured by a total body irradiation (TBI) of 700 cGy using a 137 Cs source. GFP expression and gene integration were detected after administration. The survival rate, the number of bone marrow mononuclear cells and the forming ability of CFU-GM and HPP-CFC were measured. Results: GFP expression and gene integration could be found in liver, spleen, intestine, kidney, peripheral blood and bone marrow samples of treated mice. In comparison with control mice, the treated mice had a increased survival rate. Increased numbers of bone marrow mononuclear cells, CFU-GM and HPP -CFC were observed at 7?14 days after irradiation. Conclusion: These data demonstrate for the first time that an oral PF4 17-70 gene therapy using salmonella typhimurium as carrier protects mice from TBI damage and accelerates recovery of hematopoiesis in vivo. ;
Keywords:Attenuated salmonella  Irradiation protection  Oral administration  PF4    17-70
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国生物工程杂志》浏览原始摘要信息
点击此处可从《中国生物工程杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号